Insider Selling: Avanos Medical, Inc. (NYSE:AVNS) SVP Sells 7,000 Shares of Stock

Avanos Medical, Inc. (NYSE:AVNS - Get Free Report) SVP Kerr Holbrook sold 7,000 shares of Avanos Medical stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $15.25, for a total value of $106,750.00. Following the completion of the sale, the senior vice president now owns 82,047 shares of the company's stock, valued at approximately $1,251,216.75. The trade was a 7.86 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Avanos Medical Trading Down 0.1 %

Shares of Avanos Medical stock traded down $0.02 during trading on Friday, hitting $14.45. 333,565 shares of the company were exchanged, compared to its average volume of 537,136. The firm has a market capitalization of $664.74 million, a P/E ratio of 42.50 and a beta of 1.17. Avanos Medical, Inc. has a 1-year low of $14.25 and a 1-year high of $25.36. The firm's fifty day moving average price is $15.90 and its 200 day moving average price is $19.05. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46.

Avanos Medical (NYSE:AVNS - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.03. The company had revenue of $179.60 million during the quarter, compared to analyst estimates of $177.23 million. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. As a group, sell-side analysts expect that Avanos Medical, Inc. will post 1.32 earnings per share for the current fiscal year.

Remove Ads

Hedge Funds Weigh In On Avanos Medical

Institutional investors and hedge funds have recently modified their holdings of the business. Quarry LP acquired a new position in shares of Avanos Medical in the 3rd quarter valued at approximately $42,000. Quantbot Technologies LP acquired a new position in shares of Avanos Medical in the 4th quarter valued at approximately $64,000. KBC Group NV grew its position in shares of Avanos Medical by 63.0% in the 3rd quarter. KBC Group NV now owns 2,833 shares of the company's stock valued at $68,000 after purchasing an additional 1,095 shares during the period. State of Wyoming grew its position in shares of Avanos Medical by 132.0% in the 4th quarter. State of Wyoming now owns 5,137 shares of the company's stock valued at $82,000 after purchasing an additional 2,923 shares during the period. Finally, Tower Research Capital LLC TRC grew its position in shares of Avanos Medical by 493.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 8,075 shares of the company's stock valued at $129,000 after purchasing an additional 6,714 shares during the period. 95.17% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, StockNews.com lowered Avanos Medical from a "buy" rating to a "hold" rating in a research report on Tuesday.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.